Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.

Josiane Ragimbeau1, Elisabetta Dondi, Andrés Alcover

  • 1Unité de Signalisation des Cytokines, CNRS URA 1961, Unité de Biologie des Interactions Cellulaires, CNRS URA 1960, Institut Pasteur, Paris 75724 cedex 15, France.

The EMBO Journal
|January 30, 2003
PubMed
Summary

Tyrosine kinase 2 (Tyk2) is crucial for maintaining interferon alpha/beta receptor 1 (IFNAR1) at the cell surface. Tyk2 prevents IFNAR1 internalization and degradation, ensuring proper receptor expression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MicroRNA signatures of CD4<sup>+</sup> T cell subsets in healthy and multiple sclerosis subjects determined by small RNA-sequencing.

Journal of neuroimmunology·2025
Same author

Measuring interaction force between T lymphocytes and their target cells using live microscopy and laminar shear flow chambers.

Methods in cell biology·2025
Same author

Image processing approaches for microtubule remodeling quantification at the immunological synapse.

Methods in cell biology·2025
Same author

Clinical and biological characterization of involvement of nasal-associated lymphoid tissues in chronic lymphocytic leukemia.

American journal of hematology·2024
Same author

Editorial: Tumor microenvironment and hematological malignancies: new evidences and new questions.

Frontiers in immunology·2024
Same author

Cancer-on-a-chip model shows that the adenomatous polyposis coli mutation impairs T cell engagement and killing of cancer spheroids.

Proceedings of the National Academy of Sciences of the United States of America·2024

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Mammalian Janus kinases (Jak) associate with cytokine receptors.
  • Tyk2 (Tyrosine Kinase 2) interacts with the Type I interferon receptor subunit IFNAR1.
  • Tyk2 influences ligand binding to the interferon receptor complex.

Purpose of the Study:

  • To investigate the role of Tyk2 in the cell surface expression of IFNAR1.
  • To elucidate the mechanism by which Tyk2 affects IFNAR1 localization and stability.
  • To explore potential novel functions of Tyk2 in cytokine receptor regulation.

Main Methods:

  • Cell surface expression analysis of IFNAR1 in the presence and absence of Tyk2.
  • Immunofluorescence microscopy to determine subcellular localization of IFNAR1.

Related Experiment Videos

  • Assessment of IFNAR1 degradation rates and endocytosis.
  • Analysis of interleukin-10 receptor R2 subunit localization.

    • Main Results:

    • Tyk2 is essential for stable cell surface expression of IFNAR1.
    • In the absence of Tyk2, IFNAR1 accumulates in perinuclear endosomal compartments.
    • Tyk2 inhibits IFNAR1 endocytosis, thereby reducing its degradation.
    • Tyk2 also affects the plasma membrane localization of the IL-10 receptor R2 subunit.

    Conclusions:

    • Tyk2 plays a critical role in stabilizing IFNAR1 at the cell surface by inhibiting its endocytosis and degradation.
    • This represents a novel function for a Jak protein, distinct from its known roles in receptor exit from the ER.
    • Tyk2's function in regulating cytokine receptor internalization has implications for immune signaling and receptor trafficking.